TheScientist.com - Magazine of the Life Sciences, Every Day, Online
  Please Login or Register
  • Home
  • Community
  • Current Issue
  • Browse Archive
  • Careers
  • Video & Multimedia
  • Subscribe

Front Cover
Advertisement
Front Cover
Supplements
  • Life Sciences in
    the Greater
    Phila. Region
  • Schizophrenia
  • NC: State of the Life Sciences
  • Autoimmunity


Survey Series
  • Best Places to Work
  • $alary $urvey
  • Lab Web Site and
    Video Awards

The Scientist Daily
  • Science headlines delivered daily.
    Register today.

For Advertisers
  • Advertise with Us
  • Contact Ad Team
  • 2009 Media Kit



by SPIS MedWire

RESEARCH ROUND-UP

Cholesterol levels drop after myocardial infarction

Email: SPIS MedWire - medwire@sciencenow.com
News from The Scientist 2000, 1(1):20000904-04

Published 4 September 2000

LONDON, September 4 (SPIS MedWire). Results from the LATIN (Lipid Assessment Trial Italian Network) demonstrate that cholesterol levels drop shortly after the onset of a myocardial infarction (MI), and may also be associated with the size of the infarct. DiChiara and colleagues conducted the LATIN study to determine the variation in lipid levels through the course of acute MI and unstable angina, and to evaluate the clinical and prognostic value of measurements taken at different times. Between 1998 and 1999 the team enrolled 1275 patients with MI and 589 with unstable angina who presented to 59 coronary care units across Italy. Their data clearly demonstrate a post-admission reduction in both total cholesterol levels and LDL cholesterol, in both sets of patients. The decrease was greatest after a few days, at –7% for total cholesterol and –12% for LDL-C, and became statistically significant (p<0.001) five hours after admission. Further analysis showed that the magnitude of the variation in blood lipid levels was related to infarct size, with twice as large variations seen in patients with large infarcts. The authors used their data to estimate that failure to measure blood lipids on admission leads to 22% of MI patients and 14% of unstable angina patients not subsequently receiving lipid-lowering medication, thereby remaining at increased risk of subsequent cardiovascular events. They conclude: "In order to treat all dyslipidemic patients, cholesterol determination should be done at hospital admission. International guidelines should adopt these results and strongly recommend that blood samples for lipid measurement should be taken at admission."


Not yet registered? Get free access
 

The article you are attempting to read is Premium content which is only available to our online subscribers.

 
 

Email

Password

> Forgot Password?
> FAQ
> Subscribe

 
Not yet registered? Get free access
 

Subscribing to The Scientist is easy and inexpensive.

 

And you can choose from many options. Try us out with an online day pass starting at only $4.95. Or, get it all with unlimited online access to The Scientist Archive and door-to-door delivery of our monthly print magazine.

 
  Not yet registered? Get free access  
 

The Scientist also offers site licenses to institutions and organizations. When your librarian adds The Scientist to the library's collection, you can get unlimited online access through your place of work or study.
Recommend The Scientist today

 



About TS | Contact | Advertise | Editorial Advisory Board | Privacy Policy
© 1986-2008 The Scientist